Science Speaks continues its interview series exploring the global HIV and tuberculosis research and development efforts at the U.S. Centers for Disease Control and Prevention (CDC) with a conversation with Bess Miller, MD, MSc, who works in the Division of Global HIV/AIDS. Dr. Miller has served as associate director and team lead for HIV/TB, providing leadership in policy and implementation of TB/HIV activities in 43 resource-limited countries supported by the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR). She has worked to align PEPFAR TB/HIV priorities with the World Health Organization (WHO) policies on TB/HIV, and on the use of antiretroviral therapy (ART) in people living with HIV (PLHIV). In this interview Dr. Miller discusses the successes and challenges in implementing TB infection control in Africa, progress in deploying the GeneXpert MTB/RIF rapid TB diagnostic on the ground there, and how efforts to scale up access to ART are helping achieve goals in TB control and elimination.
The goals of controlling HIV sound like a straight forward series of three consecutive steps, one following another, when discussed in global and domestic epidemic-ending plans. […]
The announcement Wednesday of U.S. Food and Drug Administration approval of pretomanid, a new tuberculosis drug that has been part of a ground-breaking treatment regimen against […]
A randomized, multi-country clinical trial testing a regimen for treating drug-resistant tuberculosis in less than a year against the up to two-year regimen recommended by the […]
The Ebola Virus is Winning – This comprehensive analysis by J. Stephen Morrison of the Center for Strategic & International Studies explains how with unprecedented advantages […]